Funded Tech Companies

Imvax

Based in Philadelphia, Imvax is venture-backed, with investment from Invus, Ziff Capital Partners and TLP.

Company Overview

Contact Information

Company Background Information

Overview

The approach is an autologous, cell-based treatment that activates the full array of patient-specific antigens, resulting in both an innate and adaptive immune response. The company's lead program is in glioblastoma multiforme (GBM), an extremely aggressive form of brain cancer with a significant unmet need.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

7/20/2020

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

John Furey

        

Chief Financial Officer

Arthur Howe

        

Chief Medical Officer

David Andrews

        

Chief Scientific Officer

Mark Exley

        

VP - Regulatory Affairs

Catherine Kessler

        

Company Investors

• Invus
• Ziff Capital Partners
• TLP
• HP Wild Holding AG
• Magnetar Capital Return

Browse more funded tech companies:

Imvaq Therapeutics | ImVitro

Share this article

About Our VC Deals Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary